InvestorsHub Logo

$heff

10/06/14 8:44 AM

#83433 RE: $heff #83188

$SNSS ..Announces Results From Pivotal Ph3 VALOR Trial of Vosaroxin and Cytarabine in First Relapsed or Refractory AML (fail) http://t.co/aLiJVVzZNA